Neuralink IPO
Neuralink is Elon Musk's neurotechnology company developing implantable brain-computer interfaces that allow humans to control devices with their thoughts. The company began its first human clinical trials in 2024 and aims to treat paralysis and neurological conditions. Neuralink is valued at around $5 billion and represents one of the most ambitious biotech ventures.
What We Know
Neuralink raised $650 million in June 2025 at a $9-9.7 billion valuation. The company began its first human clinical trials in 2024. No IPO timeline has been announced as the company is still in early-stage clinical development.
Frequently Asked Questions
Has Neuralink had an IPO?
As of early 2026, Neuralink has not announced any plans to go public. The company remains private with no confirmed IPO filing or timeline. Sign up for alerts to get notified if Neuralink announces an IPO.
When is the Neuralink IPO date?
There is no Neuralink IPO date because the company has not announced plans to go public. An IPO could happen in the future, but no timeline has been shared. Sign up for alerts to be notified of any updates.
How can I buy Neuralink stock?
Neuralink is currently a private company with no announced IPO. If the company does go public in the future, you'll be able to buy shares through any major brokerage. Sign up for alerts to stay informed.
Stay Updated on the Neuralink IPO
Get real-time alerts when Neuralink files for an IPO, prices shares, or begins trading.
Get IPO Alerts